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Summary Between 1972 and 1982, 60 patients with histologically proven duct carcinoma in situ (DCIS)
without evidence of invasive disease were treated by surgery alone. Treatment was not randomised and was
total mastectomy (19), subcutaneous mastectomy (6) or local excision (35). Follow-up was by clinical
examination and mammography with a median follow-up of 9 years (range 4-16 years). Twenty-six patients
(43%) have recurred locally. The estimated proportion recurrence free at 7 years is 59% (95% CI 46-72%).
Local recurrence on the chest wall occurred in one patient having total mastectomy and in the chest wall or
nipple in three patients having subcutaneous mastectomy. Twenty-two patients recurred locally in the breast
after conservative surgery. The 7-year recurrence-free rates were 94%, 44% and 45% respectively in the three
groups. Of those patients who recurred locally 14/26 (54%) did so with invasive disease. Of the 34 who did not
develop local recurrence, two developed metastases. The only factor which correlated with local recurrence and
invasive local recurrence on multivariate analysis was conservative surgery (hazard ratio 4.71 (1.59-14.0),
P=0.001, and 4.05 (1.00-18.7), P=0.03, respectively). DCIS can be an aggressive local disease and local
excision may be inadequate treatment.
Duct carcinoma in situ (DCIS) is traditionally treated by
mastectomy. Theoretical arguments in favour of this app-
roach include eradication of multicentric foci of DCIS,
eradication of occult invasive foci in other breast quadrants
and prevention of local recurrence from residual DCIS. Suc-
cess following mastectomy for DCIS is demonstrated by local
recurrence rates at 5 years of between 0 and 9.2% (Ashikari
et al., 1971, 1977; Sunshine et al., 1985; Farrow, 1970; West-
brook & Gallager, 1975) and survival rates of 95% at 10
years (Sunshine et al., 1985).
However, as conservation of the breast is becoming
increasingly important in the management of early stage
invasive breast cancer and with the anticipated rise in diag-
nosis of patients with DCIS following the introduction of a
national screening programme, a more conservative approach
to treatment of pure DCIS may be appropriate.
A retrospective analysis has been undertaken to define
predictors of local recurrence and progression in patients
treated by surgery alone for pure duct carcinoma in situ in an
attempt to draw conclusions about optimal therapy.
Materials and methods
All patients who presented with pure DCIS and who were
intially treated at the Fulham Road Breast Unit, the Royal
Marsden Hospital between 1972 and 1982 have been
reviewed. Patients eligible for study were those with his-
tologically proven DCIS without invasive disease, treated by
surgery alone. Patients were excluded if their presenting his-
tology was not available for detailed review or if follow-up
was not undertaken at the Royal Marsden Hospital. Sixty
patients were evaluated.
The main presenting symptoms leading to biopsy were
either a lump (25, 42%) or nipple discharge, change or
retraction (19, 31%). Four (7%) presented with non-specific
breast pain and 12 (20%) had no breast symptoms; they were
a part of the hospital's Early Diagnostic Unit Screening
Programme for women at higher than normal risk.
Fifty-four (90%) patients had preoperative mammography
and those with suspicious areas of microcalcification were
referred for surgery. Thirty-one (52%) underwent fine needle
aspiration to confirm suspicious areas but only 27 (87%) of
these provided adequate diagnostic material.
Surgical treatment involved local excision (35, 58%) or
mastectomy - total in 19 (32%) and subcutaneous in six
(10%).
Treatment policy at that time (H.D. Sinnett et al., personal
communication) was to recommend mastectomy for patients
with 'extensive' intraduct disease; this was diagnosed
preoperatively on mammography or after the initial biopsy
had demonstrated extensive DCIS in the specimen. Mastec-
tomy was also advised for those patients with associated
Paget's disease of the nipple. All patients were given the
choice of treatment after the potential risks of local recur-
rence following conservative surgery had been explained.
Five of the six patients who chose subcutaneous mastectomy
were under 45 years of age.
Representative H & E sections were reviewed by one of us
(B.G). Margins of excision were assessed from the surgical
and pathological reports at the time of operation and were
judged to be complete in 53 (88%) cases.
Follow-up was available in all patients; (median 9 years,
range 4-16 years). Follow-up included three monthly clinical
examinations for the first two years and then at increasing
intervals. Patients who had been treated by local excision
also had yearly mammography. Aspiration cytology was not
performed routinely unless suspicious areas were found
clinically or radiographically.
Multivariate analysis was performed using Cox's regression
in a stepwise fashion.
Results
Patient clinical characteristics are shown in Table I. His-
tological subtypes of DCIS, papillary, cribriform, comedo or
solid, were distributed fairly equally between the two groups
but a number contained mixtures of more than one subtype.
The clinical signs of local recurrence were lump or
nodularity in 17 cases and nipple change or discharge in five
cases. Four cases (who were asymptomatic) were detected by
mammography without associated clinical signs.
The diagnosis of local recurrence was made clinically in
16/26 cases, mammographically in 15/20 cases and by fine
needle aspiration cytology in 10/15 cases. These are described
in Table II.
A further five biopsies for suspected local recurrence were
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Table I Patient characteristics
Total Subcutaneous Local
mastectomy mastectomy excision
Median age 54 37 50
(range) (31 -78) (29-55) (33-67)
Clinical sizea
Lump <2cm 4 (21) 2 5 (14)
>2cm 3(16) 0 2(6)
Lump of unknown 3 (16) 2 11 (31)
size/nodularity
No lump 9 (47) 2 17 (49)
Total 19 6 35
aNo significant differences between groups; figures in parentheses are
Table II Diagnosis of local recurrence in 26 women
Number ofpatients with Percentage
recurrence examined positive
Clinical examination 26 62
Mammography 20 75
Aspiration cytology 15 67
P, non-significant.
carried out. Three patients had a lump or area of localised
nodularity on clinical examination and two had suspicious
microcalcification on their mammograms. However, the
pathology in these five cases was benign.
Twenty-six patients have already recurred locally, 1/19
following total mastectomy, 3/6 after subcutaneous mastec-
tomy and 22/35 with local excision. The 7-year recurrence-
free percentages (95% confidence intervals) for the groups
were total mastectomy 94% (84-100%), subcutanous
mastectomy 44% (1 -88%) and local excision 45%
(28-55%) (X2 trend = 11.9, P<0.001).
Of those who recurred following local excision alone, 19/22
(86%) did so at or near the original site of disease, while 2/22
(10%) had Paget's disease of the nipple as the presenting
feature. Of the three patients who recurred locally after
subcutaneous mastectomy, two developed Paget's disease of
the nipple and one recurred in residual breast tissue at the
edge of the prosthesis. The mastectomy patient recurred in
the scar.
Of the 26 patients who relapsed locally, 14 did so with
invasive disease (total mastectomy 1/1, subcutaneous mastec-
tomy 1/3 and local excision 12/22). The 7-year invasive
recurrence-free percentages (95% confidence intervals) for the
groups were total mastectomy 94% (84-100%), sub-
cutaneous mastectomy 75% (32-100%) and local excision
71% (56-87%) (X2 trend = 4.17, P<0.05). Of the 12 patients
who recurred with invasive disease in the local excision
group, two have already developed metastases. A further two
patients without local recurrence have developed distant
metastases.
Figure 1 demonstrates the actuarial time to local recur-
rence in the breast. Local recurrence occurred at regular
intervals throughout follow-up in each of the three treatment
groups. Local recurrence with invasive disease similarly
occurred steadily over time (Figure 2).
There were only seven deaths, three of which were att-
ributed to causes other than cancer. Overall survival showed
a trend favouring patients with local excision (X2
trend = 3.45, P<0.06). Seven-year survival rates were 97%,
100% and 78% for the local excision, subcutaneous mastec-
tomy and total mastectomy groups respectively.
There was no evidence of an improved recurrence free rate
in 12 patients who were asymptomatic compared with those
who were symptomatic at presentation (X2 = 0.63, n.s.).
There was no difference in recurrence free rates between
patients presenting with a lump and nodularity and those
presenting without (X2 = 0.05, n.s.).
Treatment of the local recurrence depended on the original
treatment of the primary tumour and whether invasive
disease had developed (Table III). The local excision group
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was usually treated conservatively again. Four of the eight of
those treated by local excision for their first local recurrence
have recurred a second time within the breast, all at or near
the original site of disease. Two of these four have progressed
to invasive disease at second recurrence.
Univariate and multivariate analysis were performed to
determine predictors of local recurrence and invasive local
recurrence. The only factor which correlated with both local
and invasive recurrence on multivariate analysis was conser-
vative surgery. The results are summarised in Table IV.
Patients treated with conservative surgery are 4.71 times as
likely to recur locally at any particular time during follow-up
as those patients treated by mastectomy alone. Similarly,
patients treated with conservative surgery are 4.05 times as
likely to recur with locally invasive disease.
Factors which did not predict for local control on
univariate and multivariate analysis included age, original
size of tumour (patients without measurable tumours were
considered to have a size of 0) and margins of excision.
Table III Treatment of local recurrence
Initial treatment
Total Subcutaneous Local
Treatment ofrecurrence mastectomy mastectomy excision
Local excision 1 7
Local excision + RT 1 - 9
Subcutaneous mastectomy - I
Total mastectomy - 1 5
Radiotherapy alone 1l
Total 1 3 22
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Table IV Predictors of local recurrence and local recurrence with
invasive disease
Multivariate analysis Hazard ratio (95%) CI) P
Local recurrence (overall): 4.71 (1.59-14.0) 0.001
conservative surgery
Local recurrence (invasive): 4.05 (1.00-18.7) 0.03
conservative surgery
Discussion
DCIS has traditionally been treated by mastectomy with the
aim ofcure. There are three main arguments in favour of this
approach. First, the eradictation of multicentre foci of DCIS
suspected to be present in the rest of the breast. Multicentric
foci have been reported in 13-40% of breasts at subgross
sectioning (Fisher et al., 1975; Lagios, 1977; Lagios et al.,
1982; Schwartz, 1980). Second, the removal of occult invasive
disease at foci in other breast quadrants. This is estimated as
occurring in 6-21% of breasts after excision of DCIS
(Brown et al., 1976; Lagios et al., 1982; Rosen et al., 1979).
Finally, mastectomy should prevent local recurrence or
invasive disease arising from residual DCIS after local
excision. The high incidence of this residue can be as high as
56% in mastectomy specimens following initial excision of
DCIS (Rosen et al., 1979).
Recently, a more conservative approach to treatment of
pure DCIS has been advocated with the emergence ofconser-
vative management of early stage breast cancer and a reluc-
tance to treat preinvasive disease more radically than invasive
disease. With the introduction of national screening program-
mes the diagnosis of pure DCIS is expected to rise and with
it the expectation of breast conserving surgery.
Local recurrence following local excision alone in this
group of patients is 55% at 7 years. This compares with a
local recurrence rate of 23% at 3 years and 15% at 4 years
reported in two other series following excision alone for
DCIS (Fisher et al., 1986; Lagios et al., 1982). Two cases
recurred within 6 months of local excision and were thought
to represent incompletely excised tumour. Recurrences have
continued to appear throughout the follow-up period. While
local recurrence within the breast is generally controllable,
the concern is that cure has been jeopardised, as recurrence
carries with it the risk of progression to invasive disease.
Local recurrence in this series carries a 54% risk of pro-
gression to invasive disease, which is similar to that reported
in four series in which DCIS had been treated with breast
conservation (Fisher et al., 1986; Montague, 1984; Recht et
al., 1985; Zafrani et al., 1986).
From our series it would appear difficult to predict
clinically or pathologically those individual patients who are
likely to recur or progress. Pathological categories defining
precise extent of disease were not used as these could only be
correctly designated if all the tumour was examined with
multiple sections; this must be combined with an accurate
assessment of the extent of the disease using subgross
analysis in conjunction with adequate margin sampling.
Tumour size did not predict for progression to invasive
disease; but less than half of our cases presented with a
palpable tumour. There was no difference in recurrence free
rates between the group with or without tumour. This is
contrary to suggestions by Lagios et al., (1982) that the
degree of multicentricity and occult invasion are related to
tumour size.
In future selection of patients who are most likely to recur
or progress may depend on other biological markers. For
example, it has been suggested that tumour ploidy (Carpenter
et al., 1987) may be associated with an increased likelihood
of recurrence. The over expression of the oncogene c-erbB-2
reported in 44% of evaluable DCIS cases presenting to this
breast unit (Gusterson et al., 1988) may provide a marker of
biologically distinct local disease and is to be investigated
further.
From our experience it would appear that local excision
alone may be inadequate local treatment for patients presen-
ting with DCIS. Furthermore, judging from the six patients
in the group, subcutaneous mastectomy would appear to
offer no advantage over a more conservative approach. In
one of these patients diagnosis of local recurrence may have
been delayed due to the tense capsule around the prosthesis.
Mastectomy offers the best hope of local control for DCIS
raising at least the probability of cure, but this still carries a
small risk of local recurrence and metastatic disease. The
former could come from residual foci after 'incomplete'
mastectomy and the latter from undetected (micro) invasive
foci.
Follow-up and survival data are not sufficient at present to
enable a comparative statement to be made. Conclusions
about optimal therapy which may be drawn from these
pateints may not be applicable in the future when an increas-
ing number of patients are diagnosed by screening mammo-
graphy at either an earlier stage of disease or even with an
entirely different biological disease.
Local excision followed by breast irradiation may provide
an alternative approach for some patients, and results of the
EORTC Protocol (10853) and NSABP (B17) prospective
trials comparing local excision with local excision and
radiotherapy for DCIS both presenting with symptoms and
at screening are awaited.
In conclusion, until biological markers are found for those
tumours most likely to recur or progress to invasive disease,
conservative surgery for DCIS should only be considered if
careful follow-up is available and the risks of local recurrence
accepted. This work underlines the need for a national policy
for disease management and clinical trials in screen-detected
DCIS.
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